Diabetic ketoacidosis in a child on FK506 immunosuppression after a liver transplant.
The use of immunosuppressive agents is becoming more widespread, especially in the context of organ transplantation. We report a child with a complication, new-onset diabetes mellitus with diabetic ketoacidosis, associated with the use of one such agent, FK506 (tacrolimus).
Keshavarz
Reza
R
Department of Emergency Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA. Reza.Keshavarz@mssm.edu
Mousavi
Mohammad-Ali
MA
Hassani
Cameron
C
D000293:Adolescent; D003922:Diabetes Mellitus, Type 1 / Q000139:chemically induced*; D016883:Diabetic Ketoacidosis / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016031:Liver Transplantation; D016559:Tacrolimus / Q000009:adverse effects*
D007166:Immunosuppressive Agents; D016559:Tacrolimus